Abstract
Elastic fibers are found in the extracellular matrix (ECM) of tissues requiring resilience and depend on elasticity. Elastin and its degradation products have multiple roles in the oncologic process. In many malignancies, the remodeled ECM expresses high levels of the elastin protein which may have either positive or negative effects on tumor growth. Elastin cross-linking with other ECM components and the enzymes governing this process all have effects on tumorigenesis. Elastases, and specifically neutrophil elastase, are key drivers of invasion and metastasis and therefore are important targets for inhibition. Elastin degradation leads to the generation of bioactive fragments and elastin-derived peptides that further modulate tumor growth and spread. Interestingly, elastin-like peptides (ELP) and elastin-derived peptides (EDP) may also be utilized as nano-carriers to combat tumor growth. EDPs drive tumor development in a variety of ways, and specifically targeting EDPs and their binding proteins are major objectives for ongoing and future anti-cancer therapies. Research on both the direct anti-cancer activity and the drug delivery capabilities of ELPs is another area likely to result in novel therapeutic agents in the near future.
Keywords
- Elastin
- Elastic fiber
- Elastin-binding protein
- Elastosis
- Elastoma
- Extracellular matrix
- Elastase
- Neutrophil elastase
- Elastin-like peptide
- Elastin-derived peptide
- Elastin receptor
- Tumor-associated stroma
- Lysyl oxidases
- Elastin collagen cross-linking
- Tumor microenvironment
This is a preview of subscription content, access via your institution.
Buying options





References
Kielty CM, Sherratt MJ, Shuttleworth CA (2002) Elastic fibres. J Cell Sci 115:2817–2828
Mithieux SM, Weiss AS (2005) Elastin. Adv Protein Chem 70:437–461
Mecham RP (1991) Elastin synthesis and fiber assembly. Ann N Y Acad Sci 624:137–146
Nivison-Smith L and Weiss A (2011) Elastin based constructs, Regenerative medicine and tissue engineering – cells and biomaterials, Daniel Eberli, IntechOpen. https://doi.org/10.5772/23660
Bashir MM, Indik Z, Yeh H et al (1989) Characterization of the complete human elastin gene. J Biol Chem 264:8887–8891
Davidson JM, Zang MC, Zoia O, Giro MG (1995) Regulation of elastin synthesis in pathological states CIBA Found. Symp 192:81–89
Perrin S, Foster JA (1997) Developmental regulation of elastin gene expression. Crit Rev Eukaryot Gene Expr 7:1–10
Hinek A (1995) The 67 kDa spliced variant of beta-galactosidase serves as a reusable protective chaperone for tropoelastin. Ciba Found Symp 192:185–191; discussion 191-186
Indik Z, Yeh H, Ornstein-Goldstein N et al (1987) Alternative splicing of human elastin mRNA indicated by sequence analysis of cloned genomic and complementary DNA. Proc Natl Acad Sci U S A 84:5680–5684
Mithieux SM, Weiss AS (1995) Tandem integration of multiple ILV5 copies and elevated transcription in polyploid yeast. Yeast 15(11):311–316
Vrhovski B, Jensen S et al (1997) Coacervation characteristics of recombinant human tropoelastin. Eur J Biochem 250:92–98
Kagan HM, Sullivan KA (1982) Lysyl oxidase: preparation and role in elastin biosynthesis. Methods Enzymol 82 Pt A:637–650
Umeda H, Nakamura F, Suyama K (2001) Oxodesmosine and isooxodesmosine, candidates of oxidative metabolic intermediates of pyridinium cross-links in elastin. Arch Biochem Biophys 385:209–219
Shapiro SD, Endicott SK, Province MA, Pierce JA, Campbell EJ (1991) Marked longevity of human lung parenchymal elastic fibers deduced from prevalence of d-aspartate and nuclear weapons-related radiocarbon. J Clin Invest 87:1828–1834
Cheatle SGL, Cutler M (1931) Tumors of the breast – their pathology, symptoms, diagnosis and treatment. Edward Arnold &Co, London
Jackson JG, Orr JW (1957) The ducts of carcinomatous breast, with particular reference to connective-tissue change. J Pathol Bacteriol 74:265–274
Beattie JM, WEC D (1926) A textbook of special pathology, 3rd edn. William Heinemann, Ltd., London
Bernath G (1952) Amyloidosis in malignant tumor. Acta Morphol 2:137–144
Lundmark C (1972) Breast cancer and elastosis. Cancer 30:1195–1201
Shivas AA, Douglas JG (1972) The prognostic significance of elastosis in breast carcinoma. J R Coll Surg Edinb 17:315–320
Azzopardi JG, Laurini RN (1974) Elastosis in breast cancer. Cancer 33:174–183
Rolland PH, Jacquemier J, Martin PM (1980) Histological differentiation in human breast cancer is related to steroid receptors and stromal elastosis. Cancer Chemother Pharmacol 5:73–77
Parfrey NA, Doyle CT (1985) Elastosis in benign and malignant breast disease. Hum Pathol 16:674–676
Fisher ER, Redmond CK, Liu H, Pochette H, Fisher B, Collaborating NSABP investigators (1980) Correlation of estrogen receptor and pathological characteristics of invasive breast cancer. Cancer (Phila) 45:349–353
Glaubitz LC, Bowen JH, Cox ED, McCarty KS (1984) Elastosis in human breast cancer. Correlation with sex steroid receptors and comparison with clinical outcome. Arch Pathol Lab Med 108:27–30
Horwitz KB, McGuire WL (1978) Estrogen control of progesterone receptor in human breast cancer. J Biol Chem 253:2223–2228
Howat JMT, Barnes DM, Harris M, Swindell R (1983) The association of cytosol estrogen and progesterone receptors with histological features of breast cancer and early recurrence of disease. Br J Cancer 47:629–640
Master JRW, Hawkins RA, Sangster K et al (1978) Estrogen receptors, cellularity, elastosis, and menstrual status in human breast cancer. EUT J Cancer 14:303–307
Robertson AJ, Brown RA, Cree IA, McGillivray JB, Slidders W, Swanson Beck J (1981) Prognostic value of measurement of elastosis in breast carcinoma. J Clin Pathol 34:738–743
Rasmussen BB, Pedersen BV, Thorpe SM, Rose G (1985) Elastosis in relation to prognosis in primary breast carcinoma. Cancer Res 45:1428–1430
Chen Y, Klingen TA, Wik E et al (2014) Breast cancer stromal elastosis is associated with mammography screening detection, low Ki67 expression and favourable prognosis in a population-based study. Diagn Pathol 9:230–238
Masters JRW, Willis RR, King RJB, Rubens RD (1979) Elastosis and response to endocrine therapy in human breast cancer. Br J Cancer 39:536–539
Tremblay G (1974) Elastosis in tubular carcinoma of the breast. Arch Pathol 98:302–307
Martinez Hernandez A, Francis DJ, Silverberg SG (1977) Elastosis and other stromal reactions in benign and malignant breast tissue. Cancer (Phila) 40:700–706
Al-Zuhair AGH, Al-Adnani MS, Al-Bader AA, Abdulla MA (1986) Distribution and ultrastructural characterization of the stroma in scirrhous “infiltrating” carcinoma of the human breast. J Submicrosc Cytol 18:409–416
Mera SL, Davies JD (1987) Elastosis in breast carcinoma: I. Immunohistochemical characterization of elastic fibres. J Pathol 151:103–110
Krishnan R, Cleary EG (1990) Elastin gene expression in elastotic human breast cancers and epithelial cell lines. Cancer Res 50(7):2164–2171
Whitehead RH, Bertoncello I, Webber LM, Pedersen JS (1983) A new human breast carcinoma cell line (PMC 42) with stem cell characteristics. 1. Morphological characterization. J Nail Cancer Inst 70:649–661
Eto T, Suzuki H, Honda A et al (1996) The change of the stromal elastotic framework in the growth of the peripheral lung adenocarcinomas. Cancer 77:646–656
Lomax Smith JD, Azzopardi JG (1978) The hyaline cell: a distinctive feature of "mixed" salivary tumours. Histopathology 2:77–92
Kondo T, Nakazawa T, Murata S, Katoh R (2005) Stromal elastosis in papillary thyroid carcinomas. Hum Pathol 36:474–479
Isaacson C, Wainwright HC, Hamilton DG, Oh TL (1985) Hollow visceral myopathy in black south Africans. A report of 14 cases. S Afr Med J 67:1015–1017
Fukushima M, Fukuda Y, Kawamoto M, Yamanaka N (2000) Elastosis in lung carcinoma: Immunohistochemical, ultrastructural and clinical studies. Pathology Int 50:626–635
Azzopardi JG, Zayid I (1972) Elastic tissue in tumours of salivary glands. J Pathol 107:149–156
David R, Buchner A (1980) Elastosis in benign and malignant salivary gland tumors. Cancer 45:2301–2310
Jacob MP, Hornebeck W (1985) Isolation and characterization of insoluble and kappa−elastins. Front Matrix Biol 10:92–129
Partridge SM, Davies HF, Adair GS (1955) The chemistry of connective tissues. 2. Soluble protein derived from partial hydrolysis of elastin. Biochem J 61:11–21
Hornebeck W, Emonard H, Monboisse JC, Bellon G (2002) Matrix-directed regulation of pericellular proteolysis and tumor progression. Semin Cancer Biol 12:231–241
Pardo A, Selman M (1999) Proteinase-antiproteinase imbalance in the pathogenesis of emphysema: the role of metalloproteinases in lung damage. Histol Histopathol 14:227–233
Fulop T, Larbi A (2002) Putative role of 67 kDa elastin-laminin receptor in tumor invasion. Semin Cancer Biol 12:219–229
Jacob MP, Fulop T Jr, Foris G, Robert L (1987) Effect of elastin peptides on ion fluxes in mononuclear cells, fibroblasts, and smooth muscle cells. Proc Natl Acad Sci U S A 84:995–999
Faury G, Garnier S, Weiss AS et al (1998) Action of tropoelastin and synthetic elastin sequences on vascular tone and on free Ca2+ level in human vascular endothelial cells. Circ Res 82:328–336
Senior RM, Griffin GL, Mecham RP (1980) Chemotactic activity of elastin-derived peptides. J Clin Invest 66:859–862
Hauck M, Seres I, Kiss I et al (1995) Effects of synthesized elastin peptides on human leukocytes. Biochem Mol Biol Int 37:45–55
Fulop T Jr, Jacob MP, Varga Z et al (1986) Effect of elastin peptides on human monocytes includes Ca2+ mobilization, stimulation of respiratory burst and enzyme secretion. Biochem Biophys Res Commun 141:92–98
Hance KA, Tataria M, Ziporin SJ, Lee JK, Thompson RW (2001) Monocyte chemotactic activity in human abdominal aortic aneurysms: role of elastin degradation peptides and the 67–kD cell surface elastin receptor. J Vasc Surg 35:254–261
Pocza P, Suli-Vargha H, Darvas Z, Falus A (2008) Locally generated VGVAPG and VAPG elastin-derived peptides amplify melanoma invasion via the galectin-3 receptor. Int J Cancer 122:1972–1980
Devy J, Duca L, Cantarelli B et al (2010) Elastin-derived peptides enhance melanoma growth in vivo by upregulating the activation of Mcol-A (MMP-1) collagenase. Br J Cancer 103:1562–1570
Mochizuki S, Brassart B, Hinek A (2002) Signaling pathways transduced through the elastin receptor facilitate proliferation of arterial smooth muscle cells. J Biol Chem 277:44854–44863
Jung S, Hinek A, Tsugu A et al (1999) Astrocytoma cell interaction with elastin substrates: implications for astrocytoma invasive potential. Glia 25:179–189
Hinek A, Jung S, Rutka JT (1999) Cell surface aggregation of elastin receptor molecules caused by suramin amplified signals leading to proliferation of human glioma cells. Acta Neuropathol 97:399–407
Devy J, Duca L, Cantarelli B et al (2010) Elastin-derived peptides enhance melanoma growth in vivo by upregulating the activation of Mcol-A(MMP-1) collagenase. Br J Cancer 103:1562–1570
Westermarck J, Kahari VM (1999) Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 13:781–792
Brassart B, Fuchs P, Huet E et al (2001) Conformational dependence of collagenase (matrix metalloproteinase- 1) up-regulation by elastin peptides in cultured fibroblasts. J Biol Chem 276:5222–5227
Huet E, Brassart B, Cauchard JH et al (2002) Cumulative influence of elastin peptides and plasminogen on matrix metalloproteinase activation and type I collagen invasion by HT-1080fibrosarcomacells. Clin Exp Metastasis 19:107–117
Toupance S, Brassart B, Rabenoelina F et al (2012) Elastin-derived peptides increase invasive capacities of lung cancer cells by post-transcriptional regulation of MMP-2 and uPA. Clin Exp Metastasis 29:511–522
Hinek A, Wrenn DS, Mecham RP, Barondes SH (1988) The elastin receptor: a galactoside-binding protein. Science 239:1539–1541
Mecham RP, Hinek A, Entwistle R et al (1989) Elastin binds to a multifunctional 67 kilodalton peripheral membrane protein. Biochemistry 28:3716–3722
Privitera S, Prody CA, Callahan JW et al (1998) The 67-kDa enzymatically inactive alternatively spliced variant of beta galactosidase is identical to the elastin/laminin-binding protein. J Biol Chem 273:6319–6326
Salesse S, Guillot A, Blaise S et al (2016) The elastin receptor complex: a unique matricellular receptor with high anti-tumoral potential. Front Pharmacol 7(32):1–10
Duca L, Blanchevoye C, Cantarelli B et al (2007) The elastin receptor complex transduces signals through the catalytic activity of its Neu-1 subunit. J Biol Chem 282:12484–12491
Brassart B, Fuchs P, Huet E et al (2001) Conformational dependence of collagenase (matrix metalloproteinase-1) up-regulation by elastin peptides in cultured fibroblasts. J Biol Chem 276:5222–5227
Floquet N, Héry-Huynh S, Dauchez M et al (2004) Structural characterization of VGVAPG, an elastin-derived peptide. Biopolymers 76:266–280
Fuchs PFJ, Bonvin AMJJ, Bochicchio B et al (2006) Kinetics and thermodynamics of type VIII beta-turn formation: a CD, NMR, and microsecond explicit molecular dynamics study of the GDNP tetrapeptide. Biophys J 90:2745–2759
Moroy G, Alix AJP, Héry-Huynh S (2005) Structural characterization of human elastin derived peptides containing the GXXP sequence. Biopolymers 78:206–220
Plow EF, Haas TA, Zhang L et al (2000) Ligand binding to integrins. J Biol Chem 275:21785–21788
Humphries JD, Byron A, Humphries MJ (2006) Integrin ligands at a glance. J Cell Sci 119:3901–3903
Bax DV, Rodgers UR, Bilek MMM et al (2009) Cell adhesion to tropoelastin is mediated via the C-terminal GRKRK motif and integrin alphaVbeta3. J Biol Chem 284:28616–28623
Pocza P, Süli-Vargha H, Darvas Z et al (2008) Locally generated VGVAPG and VAPG elastin-derived peptides amplify melanoma invasion via the galectin-3 receptor. Int J Cancer 122:1972–1980
Ochieng J, Furtak V, Lukyanov P (2004) Extracellular functions of galectin-3. Glycoconj J 19:527–535
Wang Y, Nangia-Makker P, Tait L et al (2009) Regulation of prostate cancer progression by galectin-3. Am J Pathol 174:1515–1523
Ochieng J, Warfield P, Green-Jarvis B et al (1999) Galectin-3 regulates the adhesive interaction between breast carcinoma cells and elastin. J Cell Biochem 75:505–514
Despanie J, Dhandhukia JP, Hamm-Alvarez SF, MacKay A (2016) Elastin-like polypeptides: therapeutic applications for an emerging class of nanomedicines. J Control Release 28(240):93–108
McDaniel JR, Callahan DJ, Chilkoti A (2010) Drug delivery to solid tumors by elastin-like polypeptides. Adv Drug Deliv Rev 62(15):1456–1467
Sarangthem V, Kim Y, Singh TD et al (2016) Multivalent targeting based delivery of therapeutic peptide using AP1-ELP carrier for effective cancer therapy. Theranostics 6:2235–2249
Sarangthem V, Cho EA, Yi A, Kim SK, Lee BH, Park RW (2018) Application of Bld-1-embedded elastin-like polypeptides in tumor targeting. Sci Rep 8:3892
Robert L, Jacob MP, Fülop T, Timar J, Hornebeck W (1989) Elastonectin and the elastin receptor. Pathol Biol (Paris) 37:736–741
Meyer DE, Kong GA, Dewhirst MW, Zalutsky MR, Chilkoti A (2001) Targeting a genetically engineered elastin-like polypeptide to solid tumors by local hyperthermia. Cancer Res 61:1548–1554
Schmitt M, Janicke F, Graeff H (1992) Proteases, matrix degradation and tumor cell spread. Fibrinolysis 6(Suppl 4):1–170
Nakajima M, Chop AM (1991) Tumor invasion and extracellular matrix degradative enzymes: regulation of activity by organ factors. Semin Cancer Biol 2:115–127
Carter RL (1982) Some aspects of the metastatic process. J Clin Pathol 35:1041–1049
Morihara K, Tsuzuki H (1967) Arch Biochem Biophys 120:68–78
Janoff A, Schere J (1968) Elastolytic activity in granules of human polymorphonuclear leukocytes. J Exp Med 128:1137–1156
Baugh RJ, Travis J (1976) Human leukocyte granule elastase: rapid isolation and characterization. Biochemistry 15:836–841
Banda MJ, Werb Z (1981) Mouse macrophage elastase. Biochem J 193:589–605
Kessenbrock K, Fröhlich L, Sixt M, Lämmermann T et al (2008) Proteinase 3 and neutrophil elastase enhance inflammation in mice by inactivating antiinflammatory progranulin. J Clin Invest 118:2438–2447
Henry CM, Sullivan GP, Clancy DM, Afonina IS, Kulms D, Martin SJ (2016) Neutrophil-derived proteases escalate inflammation through activation of IL-36 family cytokines. Cell Rep 14:708–722
Shapiro SD, Goldstein NM, Houghton AM, Kobayashi DK, Kelley D, Belaaouaj A (2003) Neutrophil elastase contributes to cigarette smoke-induced emphysema in mice. Am J Pathol 163:2329–2335
Gregory AD, Kliment CR, Metz HE et al (2015) Neutrophil elastase promotes myofibroblast differentiation in lung fibrosis. J Leukoc Biol 98:143–152
Alfaidi M, Wilson H, Daigneault M et al (2015) Neutrophil elastase promotes interleukin-1beta secretion from human coronary endothelium. J Biol Chem 290:24067–24078
Lapis K, Tímár J (2002) Role of elastin–matrix interactions in tumor progression. Semin Cancer Biol 12:209–217
Hornebeck W, Derouette JC, Brechemier D, Adnet JJ, Robert L (1977) Elastogenesis and elastinolytic activity in human breast cancer. Biomedicine 26:48–52
Kao RT, Wong M, Stern R (1982) Elastin degradation by proteases from cultured human breast cancer cells. Biochem Biophys Res Commun 105:383–389
Zeydel M, Nakagawa S, Biempica L, Takahashi S (1986) Collagenase and elastase production by mouse mammary adenocarcinoma primary cultures and cloned cells. Cancer Res 46:6438–6445
Grant AJ, Lerro KA, Wu CW (1990) Cell associated elastase activities of rat mammary tumour cells. Biochem Int 22:1077–1084
Sato T, Takahashi S, Mizumoto T et al (2006) Neutrophil elastase and cancer. Surg Oncol 15:217–222
Shapiro SD, Goldstein NM, Houghton AM et al (2003) Neutrophil elastase contributes to cigarette smoke-induced emphysema in mice. Am J Pathol 163:2329–2335
Vaguliene N, Zemaitis M, Lavinskiene S, Miliauskas S, Sakalauskas R (2013) Local and systemic neutrophilic inflammation in patients with lung cancer and chronic obstructive pulmonary disease. BMC Immunol 14:36–47
Kristensen JH, Karsdal MA, Sand JM et al (2015) Serological assessment of neutrophil elastase activity on elastin during lung ECM remodeling. BMC Pulm Med 15:53
Kistowski M, Dębski J, Karczmarski J et al (2017) A strong neutrophil elastase proteolytic fingerprint marks the carcinoma tumor proteome. Mol Cell Proteomics 16:213–227
Akizuki M, Fukutomi T, Takasugi M et al (2007) Prognostic significance of immunoreactive neutrophil elastase in human breast cancer: long-term follow-up results in 313 patients. Neoplasia 9:260–264
Foekens JA, Ries C, Look MP, Gippner-Steppert C, Klijn JG, Jochum M (2003) The prognostic value of polymorphonuclear leukocyte elastase in patients with primary breast cancer. Cancer Res 63:337–341
Cools-Lartigue J, Spicer J, McDonald B et al (2013) Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis. J Clin Invest 123:3446–3458
Lerman I, Hammes SR (2018) Neutrophil elastase in the tumor microenvironment. Steroids 133:96–101
Park J, Wysocki RW, Amoozgar Z et al (2016) Cancer cells induce metastasis-supporting neutrophil extracellular DNA traps. Sci Transl Med 8(361):361ra138
Miller-Ocuin JL, Liang X, Boone BA et al (2019) DNA released from neutrophil extracellular traps (NETs) activates pancreatic stellate cells and enhances pancreatic tumor growth. Onco Targets Ther 8(9):e1605822
Shang K, Bai Y, Wang C et al (2012) Crucial involvement of tumor-associated neutrophils in the regulation of chronic colitis-associated carcinogenesis in mice. PLoS One 7:e51848
Steele CW, Karim SA, Leach JDG et al (2016) CXCR2 inhibition profoundly suppresses metastases and augments immunotherapy in pancreatic ductal adenocarcinoma. Cancer Cell 29:832–845
Toh B, Wang X, Keeble J et al (2011) Mesenchymal transition and dissemination of cancer cells is driven by myeloid-derived suppressor cells infiltrating the primary tumor. PLoS Biol 9(9):e1001162
Smith-Mungo LI, Kagan HM (1998) Lysyl oxidase: properties, regulation and multiple functions in biology. Matrix Biol 16:387–398
Wang SX, Mure M, Medzihradszky KF et al (1996) A crosslinked cofactor in lysyl oxidase: redox function for amino acid side chains. Science 273:1078–1084
Moon H, Finney J, Ronnebaum T, Mure M (2014) Human Lysyl Oxidase-like 2. Bioorg Chem 57:231–241
Rucker RB, Kosonen T, Clegg MS et al (1998) Copper, lysyl oxidase, and extracellular matrix protein cross-linking. Am J Clin Nutr 67:996S–1002S
Moon H, Finney J, Ronnebaum T, Mure M (2014) Human Lysyl oxidase-like 2. Bioorg Chem 57:231–241
Johnston KA, Lopez KM (2018) Lysyl oxidase in cancer inhibition and metastasis. Cancer Letters 417:174e181
Fitzgerald J, Bateman JF (2001) A new FACIT of the collagen family: COL21A1. FEBS Lett 505:275–280
Yamauchi M, Sricholpech M (2012) Lysine post-translational modifications of collagen. Essays Biochem 52:113–133
Rosenbloom J (1987) Elastin: an overview. Meth Enzymol 144:172–196
Levental KR, Yu H, Kass L et al (2009) Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 25(139):891–906
Brodsky AS, Xiong J, Yang D et al (2016) Identification of stromal marker ColXa1 and tumor inflating lymphocytess as putative predictive markers of stromal marker of response to neoadjuvant therapy in hormone positive/Her2 positive breast cancer. BMC Cancer 16:274–287
Wang Y, Lu S, Xiong J et al (2019) ColXα1 is a stromal component that Colocalizes with elastin in the breast tumor extracellular matrix. J Pathol Clin Res 5:40–52
Kao RT, Hall J, Stern R (1986) Collagen and elastin synthesis in human stroma and breast carcinoma cell lines: modulation by the extracellular matrix. Connect Tissue Res 14:245–255
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Wang, Y., Song, E.C., Resnick, M.B. (2020). Elastin in the Tumor Microenvironment. In: Birbrair, A. (eds) Tumor Microenvironment . Advances in Experimental Medicine and Biology, vol 1272. Springer, Cham. https://doi.org/10.1007/978-3-030-48457-6_1
Download citation
DOI: https://doi.org/10.1007/978-3-030-48457-6_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-48456-9
Online ISBN: 978-3-030-48457-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)